R Squared’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$994K Buy
4,503
+2,962
+192% +$819K 0.52% 30
2026
Q1
$455K Sell
1,541
-4,363
-74% -$1.3M 0.25% 103
2025
Q4
$1.61M Buy
5,904
+3,420
+138% +$929K 0.75% 19
2025
Q3
$671K Buy
2,484
+145
+6% +$39.5K 0.29% 92
2025
Q2
$645K Buy
+2,339
New +$636K 0.36% 72

Other funds holding CME

R Squared's CME Position: Q2 2026 in Review

R Squared increased its CME Group (CME) stake by 192% in Q2 2026, buying an estimated $819K and bringing the position to 4,503 shares worth $994K. The position accounts for 0.52% of the portfolio, ranked #30.

R Squared first reported a position in CME in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.61M in Q4 2025. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • R Squared held 4,503 shares of CME Group worth $994K as of Q2 2026.
  • R Squared bought 2,962 CME Group shares in Q2 2026, an estimated $819K.
  • CME Group made up 0.52% of R Squared's portfolio in Q2 2026, its #30 holding.
  • R Squared first reported a position in CME Group in Q2 2025 and has held it in 5 quarters since.
  • R Squared's CME Group position peaked at $1.61M in Q4 2025.
  • 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on R Squared's 13F filing for Q2 2026, filed 5 Aug 2026.